Yokohama, Japan

Yutaka Hara


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yutaka Hara: Innovator in Pharmaceutical Chemistry

Introduction

Yutaka Hara is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can aid in treating circulatory diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving healthcare.

Latest Patents

Yutaka Hara holds a patent for 4-hydroxypyridine derivatives, which are useful for treating circulatory diseases. The patent describes a 4-hydroxypyridine derivative represented by a specific formula, wherein R can be a methyl group or an isopropyl group. The method for preparing this derivative involves cultivating a strain belonging to Streptomyces karnatakensis. Additionally, the patent includes a pharmaceutical composition comprising the derivative and outlines a method for treating circulatory diseases by administering the compound to a patient. This patent highlights Hara's innovative approach to addressing critical health issues.

Career Highlights

Yutaka Hara is associated with Mercian Corporation, where he has been able to apply his knowledge and skills in pharmaceutical research. His work at the company has allowed him to focus on developing new therapeutic agents that can significantly impact patient care. Hara's dedication to research and innovation has positioned him as a key figure in his field.

Collaborations

Yutaka Hara has collaborated with esteemed colleagues such as Shin-ichi Hirano and Yoshio Watanabe. These collaborations have fostered a productive environment for research and development, leading to advancements in pharmaceutical chemistry.

Conclusion

Yutaka Hara's contributions to the field of pharmaceutical chemistry, particularly through his patent for 4-hydroxypyridine derivatives, demonstrate his commitment to innovation and improving healthcare outcomes. His work continues to inspire future advancements in the treatment of circulatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…